Safety and Pharmacokinetic Study of RRx-001 in Cancer Subjects

NCT01359982 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Solid Tumor
Lymphomas

Interventions

DRUG: RRx-001
DRUG: RRx-001
DRUG: RRx-001
DRUG: RRx-001
DRUG: RRx-001
DRUG: RRx-001

Sponsor

EpicentRx, Inc.